Isolation of a peptide inhibitor of human rhinovirus

Virology. 2003 Aug 15;313(1):170-83. doi: 10.1016/s0042-6822(03)00301-5.

Abstract

Cell culture-based transdominant genetic techniques provide new methods for discovering peptide/RNA modulators of cellular pathways. We applied this technology to isolate a peptide inhibitor of human rhinovirus. A green fluorescent protein (GFP)-scaffolded library of cDNA fragments was expressed in HeLa cells from a retroviral vector and screened for inhibitors of rhinovirus-mediated cell killing. A DNA clone, I421, increased cell survival in an HRV14 challenge assay from less than 0.5% to greater than 60%. It encodes a 53-amino-acid C-terminal extension of the GFP scaffold. Particular subclones of Hela cells expressing I421 (exemplified by I421dp3) show a delay in virus production and a 50-fold decrease in viral RNA levels at 6-8 h postinfection. HRV2, HRV14, and HRV16 show a dramatic decrease in plaque-forming ability on I421dp3 while Coxsackievirus B3 showed a small reduction. Levels of ICAM-1, the receptor for the main rhinovirus serotype, are not altered in I421dp3.

MeSH terms

  • Amino Acid Sequence
  • Antiviral Agents / genetics*
  • Antiviral Agents / isolation & purification
  • Antiviral Agents / pharmacology
  • Base Sequence
  • Cloning, Molecular / methods
  • Cytopathogenic Effect, Viral / drug effects
  • DNA, Complementary / biosynthesis
  • DNA, Complementary / genetics
  • Drug Design
  • Drug Evaluation, Preclinical / methods
  • Gene Library
  • Genetic Vectors
  • HeLa Cells
  • Humans
  • Molecular Sequence Data
  • Peptides / genetics*
  • Peptides / isolation & purification
  • Peptides / pharmacology
  • Placenta / chemistry
  • Retroviridae / genetics
  • Rhinovirus / drug effects*
  • Rhinovirus / physiology
  • Transfection
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • DNA, Complementary
  • Peptides